Kiniksa Pharmaceuticals International, plc
KNSA
33 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Feb 10 10:37 PM | Tessari Eben | Proposed Sale | 14,000 | $19.57 | $274.0K | — | View → |
| Jan 13, 2025 | Jan 13 10:27 PM | Tessari Eben | Proposed Sale | 14,000 | $18.24 | $255.4K | — | View → |
| Dec 16, 2024 | Dec 16 10:17 PM | Tessari Eben | Proposed Sale | 23,017 | $20.44 | $470.4K | — | View → |
| Dec 3, 2024 | Dec 3 10:25 PM | Ragosa Mark | Proposed Sale | 72,754 | $21.25 | $1.5M | — | View → |
| Nov 27, 2024 | Nov 27 10:13 PM | Megna Michael R | Proposed Sale | 17,697 | $22.45 | $397.3K | — | View → |
| Nov 18, 2024 | Nov 18 10:50 PM | Tessari Eben | Proposed Sale | 17,000 | $21.04 | $357.6K | — | View → |
| Nov 6, 2024 | Nov 6 9:11 PM | Patel Sanj K | Proposed Sale | 89,561 | $23.00 | $2.1M | — | View → |
| Oct 15, 2024 | Oct 15 8:57 PM | Tessari Eben | Proposed Sale | 17,000 | $26.87 | $456.8K | — | View → |
| Sep 23, 2024 | Sep 23 9:02 PM | Tessari Eben | Proposed Sale | 17,500 | $24.99 | $437.3K | — | View → |
| Sep 3, 2024 | Sep 3 9:17 PM | Moat Ross | Proposed Sale | 68,506 | $26.12 | $1.8M | — | View → |
| Sep 3, 2024 | Sep 3 9:16 PM | Paolini John F. | Proposed Sale | 90,217 | $26.12 | $2.4M | — | View → |
| Aug 27, 2024 | Aug 27 9:17 PM | Tessari Eben | Proposed Sale | 17,500 | $26.91 | $470.9K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Apr 8 8:45 PM | Eben TessariCHIEF STRATEGY OFFICER | Option Exercise | 2,726 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:44 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 2,694 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:43 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 9,991 | — | 0(D) | View → |
| Apr 6, 2026 | Apr 8 8:43 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 7,278 | $10.36 | 431,904(D) | View → |
| Apr 7, 2026 | Apr 8 8:41 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 2,497 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:39 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 2,477 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:38 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 3,932 | — | 0(D) | View → |
| Apr 6, 2026 | Apr 8 8:34 PM | Barry D QuartDirector | Option Exercise | 6,901 | $14.33 | 26,336(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Option Exercise | 5,975 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Grant/Award | 58,100 | $48.13 | 16,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 5,187 | — | 5,536(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Grant/Award | 54,550 | $48.13 | 15,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 21,327 | — | 25,826(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 210,300 | $48.13 | 60,100(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Grant/Award | 46,850 | $48.13 | 13,400(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 5,831 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Grant/Award | 64,700 | $48.13 | 18,500(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 5,808 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Grant/Award | 25,550 | $48.13 | 7,300(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 7,564 | — | 7,931(D) | View → |